Trademarkia Logo

Canada

C$
Trademark Search in Canada
EUROGENTEC

View On IC.GC.CA

EUROGENTEC
APPROVED

on 27 May 2025

Last Applicant/ Owned by

KANEKA EUROGENTEC SA

Rue du Bois Saint Jean 5B-4102 Seraing

BE

Serial Number

2152804 filed on 11th Oct 2021

Correspondent Address

LAVERY, DE BILLY, LLP

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

EUROGENTEC

Trademark usage description

chemical preparations and chemical reagents, namely, kits comprising of assays, buffers, enzymes, nucleotides, reagents, nucleic acid, oligonucleotide Read More

Classification Information

Class [001]
Chemical preparations and chemical reagents, namely, kits comprising of assays, buffers, enzymes, nucleotides, reagents, nucleic acid, oligonucleotides, chemical preparations, and biological compounds for use in connection with genomic testing, genotyping, sequencing, and analysis for scientific and research purposes; antibody reagents for scientific purposes, monoclonal antibodies for scientific purposes; biological products, namely, antibodies, multi-specific antibodies, antibody fragments, proteins, chimeric proteins, drug conjugates and enzymes, for use in research and development of pharmaceuticals and for manufacture of pharmaceuticals; chemical reagents for use in connection with genomic testing, genotyping, sequencing, and analysis for scientific and research purposes; diagnostic preparations for in vitro testing for scientific use.

Classification kind code

11

Class [005]
Pharmaceutical and veterinary preparations, namely, human vaccines, veterinary vaccines; pharmaceutical and veterinary preparations, namely, qPCR kits and reagents, catalogue peptides and antibodies, assay kits, therapeutic (GMP) oligonucleotides, custom critical raw material (CRM) peptides, therapeutic (GMP) peptides, antibodies for medical and veterinary all for use in the diagnostic and treatment of infectious diseases, namely, respiratory infections and eye infections, of immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis, of neurological diseases, namely, cerebral palsy, of metabolic diseases, namely, diabetes, gout, arthritis and anemia, of oncological diseases; pharmaceutical antibody preparations for use in the treatment of infectious diseases, namely, respiratory infections and eye infections, of immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis, of neurological diseases, namely, cerebral palsy, of metabolic diseases, namely, diabetes, gout, arthritis and anemia, of oncological diseases; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting infections, autoimmune diseases, cancer; synthetic peptides for pharmaceutical purposes; in vitro transcribed RNA and recombinant proteins, plasmid DNA obtained by microbial fermentation, for preclinical, clinical and commercial use for pharmaceutical and veterinary preparations in treatment of infectious diseases, such as, respiratory infections and eye infections, of immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis, of neurological diseases, namely, cerebral palsy, of metabolic diseases, namely, diabetes, gout, arthritis and anemia, of oncological diseases and genetic diseases, namely, sickle cell disease, cancer, and muscular dystrophy diseases, all-purpose disinfectants; diagnostic reagents for medical and veterinary purposes.

Classification kind code

11

Class [042]
Research and development services on chemical products in the field of genomics and proteomics; services of analysis of chemical products in the field of genomics and proteomics; working on and evaluation of chemical synthesis in the field of genomics and proteomics.

Classification kind code

11

Mark Details

Serial Number

2152804

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 13th Mar 2023		Search Recorded
Submitted for opposition 20
on 13th Mar 2023		Examiner's First Report
Submitted for opposition 223
on 13th Mar 2023		Total Provisional Refusal
Submitted for opposition 256
on 10th Oct 2022		Notification of Possible Opposition Sent
Submitted for opposition 48
on 25th Feb 2022		Agent Changed
Submitted for opposition 257
on 9th Dec 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 8th Dec 2021		Created
Submitted for opposition 31
on 8th Dec 2021		Formalized
Submitted for opposition 30
on 11th Oct 2021		Filed
Submitted for opposition 228
on 11th Oct 2021		International Registration